75%Confidence
0Views
SEC EDGARSource
2026-04-13Date
Summary
ImageneBio's filing indicates material corporate developments for this biotechnology company. This could involve research milestones, intellectual property updates, or financing activities in the competitive biotech sector.
Actionable: Examine for research progress or partnership announcements in biotechnology development.
AI Confidence: 75%
Data Points
companyImageneBio, Inc. (IMA) (CIK 0001835579)
form8-K
date2026-04-13
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now